The role of sclerostin in the development and progression of cardiovascular diseases- a potential biomarker?

Sclerostin, a glycoprotein primarily synthesized by osteocytes, is a key regulator of bone remodeling through its inhibition of the Wnt/β-catenin signaling pathway. Beyond its established role in bone metabolism, sclerostin has been identified in vas…

Preview only. Read the full abstract at the source